» Articles » PMID: 26358173

Testosterone in Women--the Clinical Significance

Overview
Specialty Endocrinology
Date 2015 Sep 12
PMID 26358173
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Testosterone is an essential hormone for women, with physiological actions mediated directly or via aromatisation to oestradiol throughout the body. Despite the crucial role of testosterone and the high circulating concentrations of this hormone relative to oestradiol in women, studies of its action and the effects of testosterone deficiency and replacement in women are scarce. The primary indication for the prescription of testosterone for women is loss of sexual desire, which causes affected women substantial concern. That no formulation has been approved for this purpose has not impeded the widespread use of testosterone by women--either off-label or as compounded therapy. Observational studies indicate that testosterone has favourable cardiovascular effects measured by surrogate outcomes; however, associations between endogenous testosterone and the risk of cardiovascular disease and total mortality, particularly in older women, are yet to be established. Adverse cardiovascular effects have not been seen in studies of transdermal testosterone therapy in women. Clinical trials suggest that exogenous testosterone enhances cognitive performance and improves musculoskeletal health in postmenopausal women. Unmet needs include the availability of approved testosterone formulations for women and studies to elucidate the contribution of testosterone to cardiovascular, cognitive, and musculoskeletal health and the risk of cancer.

Citing Articles

Influence of dehydroepiandrosterone sulphate levels on the slower age-related decline in grey matter in younger women with polycystic ovary syndrome.

Chen M, Chen C, Chang Y, Huang C, Wu W, Ho H Brain Commun. 2025; 7(1):fcaf052.

PMID: 39958263 PMC: 11829216. DOI: 10.1093/braincomms/fcaf052.


Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease.

Nerattini M, Williams S, Andy C, Carlton C, Zarate C, Boneu C PLoS One. 2025; 20(1):e0317303.

PMID: 39804890 PMC: 11729972. DOI: 10.1371/journal.pone.0317303.


Research progress on the correlation between estrogen and estrogen receptor on postmenopausal sarcopenia.

Zhang C, Feng X, Zhang X, Chen Y, Kong J, Lou Y Front Endocrinol (Lausanne). 2024; 15():1494972.

PMID: 39640884 PMC: 11617174. DOI: 10.3389/fendo.2024.1494972.


The burden of menstrual irregularities among women living with HIV in Nigeria: a comprehensive review.

Ukoaka B, Abiodun A, Daniel F, Gbuchie M, Okesanya O, Adam T Reprod Health. 2024; 21(1):156.

PMID: 39491003 PMC: 11533283. DOI: 10.1186/s12978-024-01892-0.


Supraphysiological Dose of Testosterone Impairs the Expression and Distribution of Sex Steroid Receptors during Endometrial Receptivity Development in Female Sprague-Dawley Rats.

Yusuf A, Amri M, Ugusman A, A Hamid A, Mokhtar M Int J Mol Sci. 2024; 25(18).

PMID: 39337689 PMC: 11432676. DOI: 10.3390/ijms251810202.